Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-02-20
2023-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will recruit 21 (otherwise healthy) participants who are affected by cellulite. Volunteers will be selected in order to equally fill the 3 different grades of cellulite (7 volunteers of each grade (1, 2 \& 3) - as Grade 0 is no evidence of cellulite, this category need not be included). Each volunteer will be 'sized' according to standard apparel sizing charts (as used by the manufacturer of the cycle shorts); Small (S), Medium (M), Large (L) and Extra Large (XL).
All participants will follow the same 3 stage sequence, which will involve a total of 9 short visits to The Whiteley Clinic, each lasting approximately 30 minutes. Upon completion of these visits, participants will each be offered £90 to subsidise their cost of travel - they will also be permitted to keep the low-compression apparel following the study. During each appointment, several measurements and assessment will be made:
* Standard demographics, weight, height, and any changes to dietary or exercise regimens over the trial period.
* Subjective assessment of the cellulite by the participant.
* Objective assessment and grading using the grading system described by Nunberger and Muller by the investigators
* Images of their cellulite-affected areas will be taken (this may include an area over the buttocks and an area over the thighs), using a high-resolution medical imaging (camera) system (Vectra H2 (https://www.canfieldsci.com/imaging-systems/vectra-h2-3d-imaging-system/)), to be independently assessed by Canfield Consultants and to be graded by a 'panel' of clinicians for objective classifications.
* Assessment of local lymphatic collections in the skin using a handheld lymph scanner to assess lymph accumulation (Delfin Lymphscanner, Delfin Technologies Ltd https://hadhealth.com/lymphscanner).
* During stage 2 only, participant assessment as to ease of donning and doffing the product, and comfort of wearing it.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Made-to-measure Compression Garments
NCT04901962
Compression Therapy for Acute Lower Limb Cellulitis
NCT04272814
Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite.
NCT03312946
Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1
NCT07216183
Phototherapy and Radiofrecuency for Cellulite
NCT05441917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The first stage of the trial is an induction and stabilisation phase. The participants will be seen on the first visit, the trail explained, and any questions answered. If the participant wishes to proceed, a consent form will be signed and the participant will be measured for the correct size Cell-u-Light product - but the product will NOT be given to the patient until visit 3, to prevent them from trying the product out before the trial stage.
They will then have the assessments performed and recorded. They will be given the time and dates of their next 8 weekly visits.
Visit 2 (end of week one) and visit 3 (end of week 3) will be part of stage 1. The Cell-u-light pants will not be given to the patient until visit 3 to
Stage 2:
The second stage of the trial will begin on the third visit (at the end of week 2) and will last for 4 weeks. Participants will be given the Cell-u-light low-compression apparel to wear and shown the correct method of donning and doffing. They will be instructed to wear them daily for a continuous 8-hour period. Participants can choose which 8 hours suits them best.
Participants will be instructed to remove the apparel a minimum of 2 hours before attending their appointments. This will allow time for small indentations left on the skin surface (caused by the ink-polymer pads) to dissipate, so that imaging and subjective assessments are accurate.
Stage 3:
The final stage will act as a 2 week 'wash-out' period. Participants will stop wearing the Cell-u-light and will have two final appointments at the clinic to record and observe any residual effects of the prior intervention.
Throughout the duration of the study, it will be vital that participants maintain their usual diet and exercise levels to avoid any fluctuations in weight (that may in turn affect the appearance of their cellulite). In this way, the investigators can ensure that any difference is due solely to the effects of Cell-u-Light. To further reduce deviations in weight, lymph abundance, etc. visits to the clinic will be standardised for each volunteer such that each appointment will be at the same time each week.
The trial will be performed in the clinical area in (the CQC registered) Whiteley Clinic. The temperature will be controlled and monitored to be within 20-22 centigrade. Consent for the trial and further usage of images in future publications will be obtained from all participants. \[It will not be possible to ascertain which volunteer is being described from any photography.\]
Participants will undergo non-invasive measurements, medical photographic imaging and scans to assess the following:
* Height - Only needed at the initial visit.
* Weight
* Appearance of cellulite
* Assessment of lymph in the thigh and buttock regions
* Subjective opinion of comfort and ease of donning and doffing of the apparel by participant
* Subjective grading of cellulite by participant
* Objective grading of cellulite by aesthetician
For the subjective grading of each participants' cellulite, the investigators will use the grading system described by Nunberger \& Muller. This consists of 4 grades (0, 1, 2 and 3) as seen below, however, only 3 will be used as Grade 0 is the classification for 'no cellulite present' and therefore, does not fit the purpose of our study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Use of the compression apparel
All participants
Compression pants
Patients will have 3D photos taken each week of each buttock and thigh separately. A lymph scanner will also be used for each section to provide a percentage of water content. Weight will also be taken for each visit.
The first 2 weeks the patients will wear their regular pants, and from weeks 3-7 wear the compression pants provided. Weeks 8-9 the patients will be asked to resume to regular pants again
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compression pants
Patients will have 3D photos taken each week of each buttock and thigh separately. A lymph scanner will also be used for each section to provide a percentage of water content. Weight will also be taken for each visit.
The first 2 weeks the patients will wear their regular pants, and from weeks 3-7 wear the compression pants provided. Weeks 8-9 the patients will be asked to resume to regular pants again
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can be placed into one of the sizes of the apparel (S, M, L, or XL)
* Have had no recent abdominal/leg surgery
* Are physically able to apply and remove low-compression apparel safely
Exclusion Criteria
* Any malignancy that is being actively investigated or treated
* Any medical condition that is being actively investigated or treated
* Anyone who is on special diets for weight loss or other health issues, with the exception of those on stable diets such a gluten free for coeliac.
* Previous DVT
* (Unusual/abnormal) leg swelling
* Those who have had abdominal/leg operations within 1 year
* Those who are not mobile
* Those who are pregnant or planning to get pregnant
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canfield
UNKNOWN
The Whiteley Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Whiteley
Consultant Venous Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Whiteley Clinic
Guildford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kiely MJ, Poulsen A, Muschamp SD, Sallis C, Whiteley MS. Participant Reported Improvement in Cellulite by Vari-Pad Apparel and Objective Measurements - A "First Use" Pilot Study. Clin Cosmet Investig Dermatol. 2023 Sep 20;16:2573-2583. doi: 10.2147/CCID.S426978. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TWC-SM-2022-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.